share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  06/28 08:37
Moomoo AI 已提取核心訊息
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
2024年6月27日，Safety Shot公司與一名認可的投資者簽署了證券購買協議，出售了每股1.06美元，共943,396股，與當日收盤價相符，未涉及任何折扣或佣金。交易結果爲公司帶來了約100萬美元的淨收益。值得注意的是，該投資者與該公司的總裁喬丹·沙爾(Jordan Schur)關係密切，後者在該投資實體中擁有15%的股份，且還有家庭成員是股東。此次投資是繼同一團隊在2024年4月份投資了500萬美元后的又一筆投資。這些股份是通過定向增發發行的，無需事先註冊，並依賴於免除註冊要求的豁免權利。公司還在2024年6月28日發佈了一份新聞稿，詳細介紹了這項投資並突出了總裁對公司增長和產品創新的信懇智能。Safety Shot公司是一家保健和膳食補充劑公司，以開發一種有助於代謝血液中酒精含量的專利產品而聞名。
2024年6月27日，Safety Shot公司與一名認可的投資者簽署了證券購買協議，出售了每股1.06美元，共943,396股，與當日收盤價相符，未涉及任何折扣或佣金。交易結果爲公司帶來了約100萬美元的淨收益。值得注意的是，該投資者與該公司的總裁喬丹·沙爾(Jordan Schur)關係密切，後者在該投資實體中擁有15%的股份，且還有家庭成員是股東。此次投資是繼同一團隊在2024年4月份投資了500萬美元后的又一筆投資。這些股份是通過定向增發發行的，無需事先註冊，並依賴於免除註冊要求的豁免權利。公司還在2024年6月28日發佈了一份新聞稿，詳細介紹了這項投資並突出了總裁對公司增長和產品創新的信懇智能。Safety Shot公司是一家保健和膳食補充劑公司，以開發一種有助於代謝血液中酒精含量的專利產品而聞名。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息